These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15206239)

  • 1. [Monoclonal antibodies and chemotherapy: planning and management of symptoms].
    Berardini R
    Suppl Tumori; 2004; 3(4):S130-2. PubMed ID: 15206239
    [No Abstract]   [Full Text] [Related]  

  • 2. Special nursing care for children receiving chemotherapy.
    Waskerwitz MJ
    J Assoc Pediatr Oncol Nurses; 1984; 1(1):16-25. PubMed ID: 6233417
    [No Abstract]   [Full Text] [Related]  

  • 3. Outpatient chemotherapy: telephone triage for symptom management.
    Anastasia PJ; Blevins MC
    Oncol Nurs Forum; 1997; 24(1 Suppl):13-22. PubMed ID: 9010861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proposed model for evaluation of toxicity in antineoplastic chemo-hormonotherapy].
    Pannuti F; Martoni A; Piana E; Palenzona D
    Minerva Med; 1978 Nov; 69(55):3761-72. PubMed ID: 153486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nursing guidelines and discharge planning for patients receiving recombinant interleukin-2.
    Caliendo G; Joyce D; Altmiller MC
    Semin Oncol Nurs; 1993 Aug; 9(3 Suppl 1):25-31. PubMed ID: 8210791
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoclonal antibodies and chemotherapy: therapeutic indications].
    Carrozza F
    Suppl Tumori; 2004; 3(4):S127-9. PubMed ID: 15206238
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing chemotherapy-associated toxicity in elderly cancer patients.
    Zagonel V; Fratino L; Sacco C; Babare R; Spazzapan S; Gattei V; Improta S; Pinto A
    Cancer Treat Rev; 1996 May; 22(3):223-44. PubMed ID: 8841391
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific adverse events caused by monoclonal antibodies, focusing on the prophylaxis and management].
    Akiyama S
    Nihon Rinsho; 2012 Dec; 70(12):2199-204. PubMed ID: 23259397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies for medical oncology: a few critical perspectives.
    Belda-Iniesta C; Ibáñez de Cáceres I; de Castro J
    Clin Transl Oncol; 2011 Feb; 13(2):84-7. PubMed ID: 21324795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer chemotherapy: a guide for nurses. Side-effects of chemotherapy.
    Thomson L
    Nurs Times; 1979 Jul; 75(29):Suppl 5-8. PubMed ID: 257437
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications of monoclonal antibody therapy.
    Meisel K; Rizvi S
    Med Health R I; 2011 Nov; 94(11):317-9. PubMed ID: 22204093
    [No Abstract]   [Full Text] [Related]  

  • 12. The case of anticipated alopecia.
    Eisenberg S
    ONS Connect; 2011 Jul; 26(7):17. PubMed ID: 21877440
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-targeted immunotherapy for treatment of malignancy.
    White CA; Weaver RL; Grillo-López AJ
    Annu Rev Med; 2001; 52():125-45. PubMed ID: 11160771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibody therapy: a literature review].
    Del Debbio CB; Tonon LM; Secoli SR
    Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Selfless Act.
    Cohn SL
    J Clin Oncol; 2015 Nov; 33(32):3834-5. PubMed ID: 26261250
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases].
    Hansen PB; Hasselbalch HC
    Ugeskr Laeger; 2004 Feb; 166(6):466-9. PubMed ID: 15045710
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune checkpoint inhibitors for Indian patients: A note of caution.
    Venniyoor A
    Indian J Cancer; 2016; 53(3):468-469. PubMed ID: 28244488
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-Lymphoma Monoclonal Antibodies: Making Better Antibodies and Making Antibodies Better.
    Weiner GJ
    Trans Am Clin Climatol Assoc; 2015; 126():87-92. PubMed ID: 26330662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trastuzumab-related cardiotoxicity in the herceptin adjuvant trial.
    Montemurro F; Redana S; Valabrega G; Martinello R; Aglietta M; Palmiero R
    J Clin Oncol; 2008 Apr; 26(12):2052-3; author reply 2053-4. PubMed ID: 18421060
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibodies and side-effect management.
    Muehlbauer PM; Cusack G; Morris JC
    Oncology (Williston Park); 2006 Sep; 20(10 Suppl Nurse Ed):11-21; discussion 22-3. PubMed ID: 18153975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.